With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only…
Mipsagargin (G-202), a new prodrug developed by GenSpera, has a unique mechanism of action that allows it to kill cancer cells without damaging surrounding tissues. Derived from thapsigargin,…
There are many ailments that can produce pain in the pelvic region, but one that is often overlooked or misdiagnosed is pelvic congestion syndrome (PCS). Affecting approximately 10%…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Hidradenitis suppurativa (HS) is a chronic skin condition that results in painful abscesses, nodules, inflamed follicles, and acne-like cysts on many sensitive epidermal surfaces of both men and…
Hidradenitis suppurativa (HS) is a disease of the follicle that results in painful lesions and abscesses on the skin, most often in the intertriginous areas of the body.…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
